肺癌的发病率已居当今世界各类恶性肿瘤之首，而目前治疗的效果尚不满意。近几年来，由于分子生物学等相关学科的迅猛发展，基因转移技术的不断完善，肺癌的基因治疗已取得了重大进展，并已从实验及基础研究过度到临床试用阶段，为肺癌的治疗带来了新的希望。研究认为癌症发生 The incidence of lung cancer has ranked first in all types of malignant tumors in the world today, and the effect of current treatment is not yet satisfactory. In recent years, due to the rapid development of molecular biology and other related disciplines, and the continuous improvement of gene transfer technology, significant progress has been made in the gene therapy of lung cancer, and has progressed from experimental and basic research to clinical trials. New hope came. Study considers cancer